Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Adenoviridae Infections 1

Interventions

Specimen Handling 154 pembrolizumab 133 Magnetic Resonance Spectroscopy 121 Cyclophosphamide 120 Biopsy 108 fludarabine 92 Nivolumab 61 Carboplatin 55 Radiotherapy 49 Cisplatin 49 Gemcitabine 48 venetoclax 44 Paclitaxel 43 Cetuximab 41 fludarabine phosphate 40 Ipilimumab 36 Fluorouracil 35 atezolizumab 34 Bevacizumab 33 durvalumab 30 Radiation 30 Oxaliplatin 29 X-Rays 28 Leucovorin 28 Dexamethasone 28 Cytarabine 27 Azacitidine 27 Irinotecan 26 Radiosurgery 24 Injections 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tumor Necrosis Factor-alpha × 90 days × Clear all

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡